首页> Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology> Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials.

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yang,Yang

第一单位： Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), Taizhou, Zhejiang 317502, China; Department of Thoracic Radiotherapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Wenling Institute of Big Data and Artificial Intelligence in Medicine, Taizhou, Zhejiang 317502, China.

作者： Yang,Yang ^[1] ; Rongjun,Shao ^[2] ; Xiufeng,Cao ^[3] ; Mengyuan,Chen ^[4] ; Wangang,Gong ^[5] ; Hangjie,Ying ^[6] ; Ge,Song ^[7] ; Guangxian,You ^[2] ; Guoqin,Qiu ^[4] ; Qixun,Chen ^[6] ; Yongling,Ji ^[4] ; Dong,Xu ^[8]

作者单位： Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), Taizhou, Zhejiang 317502, China; Department of Thoracic Radiotherapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Wenling Institute of Big Data and Artificial Intelligence in Medicine, Taizhou, Zhejiang 317502, China. ^[1] Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), Taizhou, Zhejiang 317502, China. ^[2] Department of Thoracic Surgery, Sir Run Run Shaw Hospital, Nanjing Medical University, Nanjing, Jiangsu 211112, China. ^[3] Department of Thoracic Radiotherapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China. ^[4] Department of Biobank, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China. ^[5] Department of Experiment Center, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China. ^[6] Department of Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China. ^[7] Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), Taizhou, Zhejiang 317502, China; Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Wenling Institute of Big Data and Artificial Intelligence in Medicine, Taizhou, Zhejiang 317502, China. Electronic address: xudong@zjcc.org.cn. ^[8]

关键词 Esophageal squamous carcinoma Neoadjuvant chemoradiotherapy Neoadjuvant chemotherapy Randomized clinical trial Surgery

医学主题词人类(Humans);食管肿瘤(Esophageal Neoplasms);肿瘤辅助疗法(Neoadjuvant Therapy);随机对照试验(主题)(Randomized Controlled Trials as Topic);存活率(Survival Rate)

DOI 10.1016/j.radonc.2024.110517

PMID 39218039

发布时间 2026-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交